FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to field of chemical-pharmaceutical industry, namely to pharmaceutical composition in form of tableted form with delayed release, which contains 30-40 wt % of clozapine as active component and additional substances: 20-35 wt % of Methocel K100 LV, 10-15 wt % of Methocel K4M, 12-30 wt % of microcrystalline cellulose, 2-3 wt % of copovidone, 0.5-1 wt % of colloidal silicon dioxide and 0.5-1 wt % of pharmaceutically acceptable salt of stearic acid, as well as to method of obtaining said pharmaceutical composition.
EFFECT: group of the inventions provides obtaining clozapine tablets, possessing stability and reproducible kinetics of delayed release of active substance.
8 cl, 4 ex, 4 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING BIOTIN AND METHOD FOR ITS PRODUCTION | 2017 |
|
RU2639488C1 |
| BIOTIN TABLETS WITH DELAYED RELEASE AND METHOD FOR OBTAINING THEREOF | 2016 |
|
RU2638803C2 |
| TABLETS OF CLOZAPINE WITH SUSTAINED RELEASE | 2016 |
|
RU2613192C1 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE WITH ANTIPSYCHOTIC ACTIVITY AND SYNTHESIS METHODS THEREOF | 2012 |
|
RU2584653C2 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| ANTIDEPRESSANT PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION | 2008 |
|
RU2377991C1 |
| IMMEDIATE RELEASE COMPOSITIONS | 2010 |
|
RU2541807C2 |
| LAMOTRIGINE-BASED COMPOSITIONS OF PROLONGED RELEASE | 2003 |
|
RU2325163C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | 2016 |
|
RU2736941C2 |
| METHODS FOR PREPARING ERGOT ALKALOIDS PHARMACEUTICAL COMPOSITIONS WITH PROLONGED EFFECT CHARACTERIZING WITH IMPROVED BIOAVAILABILITY AND COMPOSITIONS COMPRISING INDICATED ALKALOIDS | 2000 |
|
RU2256454C2 |
